• December 21, 2022• In the News

Maryland’s Prescription Drug Affordability Board finally gets off the ground. Advocates hope its strategy pays off.

The Baltimore Banner
December 20, 2022
Sarah True

Excerpt:

“… the board will release its first policy recommendations this month and a drug industry transparency initiative and insulin affordability program will follow shortly thereafter.”

Read full text at The Baltimore Banner.

Last modified: December 21, 2022
← Previous Story: Maryland Matters: Health advocates prep for ’23 session with ultimate goal of eliminating Md.’s uninsured population
→ Next Story: New Maryland state board will scrutinize hundreds of medications to slash prescription costs

Last modified: December 21, 2022

Comments are closed.

↑